Interferon-Free Study Boosts Belief in Sofosbuvir
New Hepatitis C Drug Continues Curing In Clinical Trials
As clinical trials continue to show positive results, sofosbuvir seems to be poised to gain FDA approval.
By Jonathan Weiss | Apr 24, 2013
Coming on the heels of a recent report indicating that the Hepatitis C drug sofosbuvir surpassed expectations, a Phase III clinical trial out of Weil Cornell Medical Center in New York City has shown that the result of using the drug cures most patients with two subtypes of the virus.
Continue reading this entire article:
Did Tulsa Dentist Infect Nearly 60 Patients with Hep C?
Encouraging Trial Results for Hep C Drug Faldaprevir